Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector

NCT02022696 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Human Genome Research Institute (NHGRI)

Collaborators